Uncategorized

The Erosion of the Safe Harbor: Strategic Adaptation in the Era of “Label-Plus” Liability and Regulatory Rigor

In today’s rapidly evolving pharmaceutical landscape, the once-reliable “safe harbor” strategies that shield companies from legal and regulatory pitfalls are under unprecedented threat. As drug patent landscapes become more complex and regulatory scrut…

The Erosion of the Safe Harbor: Strategic Adaptation in the Era of “Label-Plus” Liability and Regulatory Rigor Read Post »

Biotechblog
Scroll to Top